NORMAN SCHWARTZ - 06 Sep 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Issuer symbol
BIO BIOB
Transactions as of
06 Sep 2024
Net transactions value
$0
Form type
4
Filing time
10 Sep 2024, 14:07:05 UTC
Previous filing
04 Sep 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIOB Bio-Rad A Common Stock 438,238 06 Sep 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 361,466 06 Sep 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 13,006 06 Sep 2024 By Spouse F1
holding BIO BIOB Bio-Rad B Common Stock 4,060,054 06 Sep 2024 By Blue Raven Partners, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Award $0 +13,822 $0.000000 13,822 06 Sep 2024 Bio-Rad A Common Stock 13,822 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these shares.
F2 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.